MATES SHARON (Chairman, President & CEO) sold 8.8% of their position (102.70K shares) of INTRA-CELLULAR THERAPIES, INC. on the open market
Open‑market sale worth $8.72M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+51K
Price / share
$12.73
Trade value
$649.23K
% of position
Common Stock
Shares
−27.67K
Price / share
$85.62
Trade value
$2.37M
% of position
Common Stock
Shares
−23.33K
Price / share
$86.00
Trade value
$2.01M
% of position
Common Stock
Shares
+51.70K
Price / share
$12.73
Trade value
$658.10K
% of position
Common Stock
Shares
−50.16K
Price / share
$84.06
Trade value
$4.22M
% of position
Common Stock
Shares
−1.53K
Price / share
$84.69
Trade value
$129.91K
% of position
Net shares
+0.00
Net value
-$7.42M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/4/2024 | M · Option Exercise | +51K | $12.73 | $649.23K | 4.8% | 1.07M | 1.12M |
| Common Stock Direct | 12/4/2024 | S · Sale | −27.67K | $85.62 | $2.37M | 2.5% | 1.12M | 1.09M |
| Common Stock Direct | 12/4/2024 | S · Sale | −23.33K | $86.00 | $2.01M | 2.1% | 1.09M | 1.07M |
| Common Stock Direct | 12/5/2024 | M · Option Exercise | +51.70K | $12.73 | $658.10K | 4.8% | 1.07M | 1.12M |
| Common Stock Direct | 12/5/2024 | S · Sale | −50.16K | $84.06 | $4.22M | 4.5% | 1.12M | 1.07M |
| Common Stock Direct | 12/5/2024 | S · Sale | −1.53K | $84.69 | $129.91K | 0.1% | 1.07M | 1.07M |
| Total | +0.00 | -$7.42M | ||||||
Stock Option (right to buy)
Common Stock
51K shares
Shares
−51K
Strike price
12.73
Held after
51.70K
Exercisable
—
Stock Option (right to buy)
Common Stock
51.70K shares
Shares
−51.70K
Strike price
12.73
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock51K shares | 12/4/2024 | M · Option Exercise | −51K | 12.73 | — | 51.70K |
| Stock Option (right to buy) Direct | Common Stock51.70K shares | 12/5/2024 | M · Option Exercise | −51.70K | 12.73 | — | 0.00 |